In April, 2025, Demis Hassabis, the Nobel Prize-winning CEO of Google DeepMind, appeared on the US television show 60 Minutes and suggested that all diseases could be curable with the help of ...

As early as 2005, Gritz and colleagues drew attention to clinical trialists missing the potential impact of tobacco use on cancer treatment outcomes, as smoking status was rarely recorded in cancer ...

With 22% of service robot shipment, the firm’s Shanghai debut has an ecosystem strategy- pairing humanoids with delivery and medical robots.

In a new 15‑second clip, Korea’s ARMstrong Dex humanoid robot proves its agility by hurling a 500 ml bottle into a barrel.

Researchers at Johns Hopkins University have developed SRT-H, an AI that autonomously guided a da Vinci robot through complex ...

A laundry-stealing cat with expensive taste has puzzled and delighted a neighborhood in Auckland, New Zealand, by committing ...

Dispatch Bio launched with $216 million – backed primarily by Parker Institute for Cancer Immunotherapy, founded by entrepreneur Sean Parker, and ARCH Venture Partners. SAB BIO announced an ...

Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company” or “Rakovina”) a biopharmaceutical company advancing cancer therapies through artificial intelligence (AI)-powered drug discovery ...

A team used generative AI to enhance T cells’ ability to fight melanoma. The immunotherapy approach needs more testing before use in cancer patients.

This digital health care company seeks to support women through every stage of womanhood, even—and especially—the ...

Group net sales grow by 6.3%* to EUR 14.0 billion, driven by Human Pharma (EUR 11.3 billion) and Animal Health (EUR 2.6 billion)Regulatory submissions underway for zongertinib and nerandomilast, with ...